BioGenerator Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Panome Biopanomebio.cominMar 2023
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types.
AI & Machine LearningBiotechDeep TechHealthtechSaint Louis, US
Edward Weinstein(Executive Officer, Director)inTom Cohen(Executive Officer)in
BoardDavid Smoller(Director)inDeval Lashkari(Director)inAlexander Herzick(Director)inRob Capone(Director)in
Co-investorsTelegraph Hill PartnersCultivation Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.